参考文献/References:
[1]中华人民共和国国务院.国务院关于印发“十三五”国家老龄事业发展和养老体系建设规划的通知[EB/OL].http://www.gov.cn/zhengce/content/2017-03/06/content_5173930.htm,2017-03-06/2021-9-01.[2]NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants[J].Lancet,2017,389(10064):37-55. [3]GBD 2017 Risk Factor Collaborators.Global,regional,and national comparative risk assessment of 84 behavioural,environmental and occupational,and metabolic risks or clusters of risks for 195 countries and territories,1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2018,392(10159):1923-1994. [4]Williams B,Mancia G,Spiering W,et al.2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension[J].J Hypertens,2018,36(12):2284-2309.[5]李静,范利,华琦,等.中国老年高血压管理指南2019[J].中华高血压杂志,2019,27(2):111-135.[6]Vetrano DL,Palmer KM,Galluzzo L,et al.Hypertension and frailty: a systematic review and meta-analysis[J].BMJ Open,2018,8(12):e024406.[7]Post Hospers G,Smulders YM,Maier AB,et al.Relation between blood pressure and mortality risk in an older population: role of chronological and biological age[J].J Intern Med,2015,277(4):488-497. [8]Ravindrarajah R,Hazra NC,Hamada S,et al.Systolic Blood Pressure Trajectory,Frailty,and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records[J].Circulation,2017,135(24):2357-2368.[9]董莉娟. 社区老年人衰弱与生存质量的关系研究[D].济南:山东大学,2017.[10]范利,李建华,胡亦新,等.合并不同并发症的老年高血压患者的衰弱检出率[J].中华高血压杂志,2015,23(12):1151-1155.[11]Dent E,LienC,Lim WS,et al.The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty[J].J Am Med Dir Assoc,2017,18(7):564-575. [12]Van Hateren KJ,Hendriks SH,Groenier KH,et al.Frailty and the relationship between blood pressure and mortality in elderly patients with type 2 diabetes (Zwolle Outpatient Diabetes project Integrating Available Care-34)[J].J Hypertens,2015,33(6):1162-1166. [13]胡亦新,范利.老年高血压合并衰弱的临床研究和管理进展——《中国老年高血压管理指南2019》解读[J].中华高血压杂志,2019,27(10):910-913.[14]Carneiro JA,Cardoso RR,Dur?es MS,et al.Frailty in the elderly: prevalence and associated factors[J].Rev Bras Enferm,2017,70(4):747-752.[15]Carneiro JA,Ramos GC,Barbosa AT,et al.Prevalence and factors associated with frailty in non-institutionalized older adults[J].Rev Bras Enferm,2016,69(3):435-442.[16]Gobbens RJ,Van Assen MA.Explaining frailty by lifestyle[J].Arch Gerontol Geriatr,2016(66):49-53.[17]金蓉.农村老年高血压患者居家安全风险与衰弱指数的关系[D].唐山:华北理工大学,2018.[18]Reinders I,Visser M,Schaap L.Body weight and body composition in old age and their relationship with frailty[J].Curr Opin Clin Nutr Metab Care,2017,20(1):11-15.[19]Saltiel AR,Olefsky JM.Inflammatory mechanisms linking obesity and metabolic disease[J].J Clin Invest,2017,127(1):1-4.[20]Fuentes E,Fuentes M,Alarcón M,et al.Immune System Dysfunction in the Elderly[J].An Acad Bras Cienc,2017,89(1):285-299. [21]罗勇,黄金玲.8周有氧运动对肥胖小鼠骨骼肌炎症及运动能力的影响[J].中国实验动物学报,2021,29(5):637-643. [22]Nascimento CM,Ingles M,Salvador-Pascual A,et al.Sarcopenia, frailty and their prevention by exercise[J].Free Radic Biol Med,2019(132):42-49.[23]Ma L,Zhang L,Sun F,et al.Frailty in Chinese older adults with hypertension: Prevalence, associated factors, and prediction for long-term mortality[J].J Clin Hypertens (Greenwich),2018, 20(11):1595-1602.[24]王继,杨中亚,张龙,等.AMPK/PGC-1α在有氧运动改善2型糖尿病大鼠骨骼肌萎缩中的作用[J].中国组织工程研究,2020,24(20):3180-3185.[25]Kim H,Jang M,Park R,et al.Conessine Treatment Reduces Dexamethasone-Induced Muscle Atrophy by Regulating MuRF1 and Atrogin-1 Expression[J].J Microbiol Biotechnol,2018,28(4):520-526.[26]郝秋奎,李峻,董碧蓉,等.老年患者衰弱评估与干预中国专家共识[J].中华老年医学杂志,2017,36(3):251-256. [27]Dong L,Liu N,Tian X,et al.Reliability and validity of the Tilburg Frailty Indicator (TFI) among Chinese community-dwelling older people[J].Arch Gerontol Geriatr,2017(73):21-28.
相似文献/References:
[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(03):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(03):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(03):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(03):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(03):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]姜小红,严琴琴,周连锁,等.老年衰弱的干预措施现状研究[J].医学信息,2022,35(09):76.[doi:10.3969/j.issn.1006-1959.2022.09.019]
JIANG Xiao-hong,YAN Qin-qin,ZHOU Lian-suo,et al.Study on the Current Situation of Intervention Measures for Elderly Frailty[J].Medical Information,2022,35(03):76.[doi:10.3969/j.issn.1006-1959.2022.09.019]
[7]孔玉涛.虚拟现实技术改善老年人衰弱状态的研究现状[J].医学信息,2022,35(09):54.[doi:10.3969/j.issn.1006-1959.2022.09.013]
KONG Yu-tao.Research Status of Virtual Reality Technology in Improving Aged Frailty[J].Medical Information,2022,35(03):54.[doi:10.3969/j.issn.1006-1959.2022.09.013]
[8]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Medical Information,2022,35(03):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[9]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(03):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[10]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者
轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(03):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]